Schedule 3A SUPPLEMENTARY LICENCE CONDITIONS: HUMAN APPLICATIONF1

United Kingdom

1. A1Paragraph A1
2. Modification of the definition of partner donation in the second Directive
3. Traceability system
4. Serious adverse events and serious adverse reactions : Great Britain
5. Serious adverse events and serious adverse reactions: Northern Ireland
6. Third party agreements and termination of licensed activities
7. Requirements for procurement of gametes and embryos
8. Selection criteria and laboratory tests required for donors of reproductive cells
9. Donation and procurement procedures and reception at the tissue establishment
10. Requirements for holding a licence under paragraph 1, 1A or 2 of Schedule 2
11. Requirements for holding a licence for gametes and embryo preparation processes
12. Modifications to the first, second and third Directives
13. Interpretation of this Schedule